Vistagen Therapeutics Statistics
Total Valuation
VTGN has a market cap or net worth of $69.72 million. The enterprise value is -$25.17 million.
Important Dates
The last earnings date was Thursday, November 7, 2024, after market close.
| Earnings Date | Nov 7, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
VTGN has 27.06 million shares outstanding. The number of shares has increased by 284.96% in one year.
| Current Share Class | 27.06M |
| Shares Outstanding | 27.06M |
| Shares Change (YoY) | +284.96% |
| Shares Change (QoQ) | +0.09% |
| Owned by Insiders (%) | 0.26% |
| Owned by Institutions (%) | 24.53% |
| Float | 17.37M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 90.29 |
| Forward PS | n/a |
| PB Ratio | 0.76 |
| P/TBV Ratio | 0.76 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 13.29, with a Debt / Equity ratio of 0.02.
| Current Ratio | 13.29 |
| Quick Ratio | 12.97 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -61.52% and return on invested capital (ROIC) is -42.93%.
| Return on Equity (ROE) | -61.52% |
| Return on Assets (ROA) | -39.39% |
| Return on Capital (ROIC) | -42.93% |
| Revenue Per Employee | $21,900 |
| Profits Per Employee | -$989,125 |
| Employee Count | 40 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, VTGN has paid $8,000 in taxes.
| Income Tax | 8,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -22.78% in the last 52 weeks. The beta is 0.78, so VTGN's price volatility has been lower than the market average.
| Beta (5Y) | 0.78 |
| 52-Week Price Change | -22.78% |
| 50-Day Moving Average | 3.01 |
| 200-Day Moving Average | 3.85 |
| Relative Strength Index (RSI) | 28.92 |
| Average Volume (20 Days) | 271,987 |
Short Selling Information
The latest short interest is 528,162, so 1.95% of the outstanding shares have been sold short.
| Short Interest | 528,162 |
| Short Previous Month | 644,717 |
| Short % of Shares Out | 1.95% |
| Short % of Float | 3.04% |
| Short Ratio (days to cover) | 2.62 |
Income Statement
In the last 12 months, VTGN had revenue of $876,000 and -$39.57 million in losses. Loss per share was -$1.31.
| Revenue | 876,000 |
| Gross Profit | 876,000 |
| Operating Income | -45.60M |
| Pretax Income | -29.36M |
| Net Income | -39.57M |
| EBITDA | -45.47M |
| EBIT | -45.60M |
| Loss Per Share | -$1.31 |
Full Income StatementBalance Sheet
The company has $97.58 million in cash and $1.79 million in debt, giving a net cash position of $95.78 million or $3.54 per share.
| Cash & Cash Equivalents | 97.58M |
| Total Debt | 1.79M |
| Net Cash | 95.78M |
| Net Cash Per Share | $3.54 |
| Equity (Book Value) | 92.97M |
| Book Value Per Share | 3.44 |
| Working Capital | 92.43M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$33.49 million and capital expenditures -$164,000, giving a free cash flow of -$33.65 million.
| Operating Cash Flow | -33.49M |
| Capital Expenditures | -164,000 |
| Free Cash Flow | -33.65M |
| FCF Per Share | -$1.24 |
Full Cash Flow StatementMargins
| Gross Margin | 100.00% |
| Operating Margin | -5,205.59% |
| Pretax Margin | -4,515.64% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | -2,431.77% |
Dividends & Yields
VTGN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -284.96% |
| Shareholder Yield | -284.96% |
| Earnings Yield | -56.03% |
| FCF Yield | -47.65% |
Analyst Forecast
The average price target for VTGN is $15.00, which is 482.12% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $15.00 |
| Price Target Difference | 482.12% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | 201.61% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
The last stock split was on June 7, 2023. It was a reverse split with a ratio of 0.0333333:1.
| Last Split Date | Jun 7, 2023 |
| Split Type | Reverse |
| Split Ratio | 0.0333333:1 |
Scores
VTGN has an Altman Z-Score of 1.28 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.28 |
| Piotroski F-Score | 1 |